Immediate Impact

43 standout
Sub-graph 1 of 19

Citing Papers

Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2025 Standout
Challenges and opportunities for digital twins in precision medicine from a complex systems perspective
2025 Standout
1 intermediate paper

Works of Enio Gjerga being referenced

Causal integration of multi‐omics data with prior knowledge to generate mechanistic hypotheses
2021
Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer—findings from the RIBECCA trial
2021

Author Peers

Author Last Decade Papers Cites
Enio Gjerga 205 28 6 41 16 260
Alan D. Stern 148 33 22 32 16 261
Joseph Hackett 191 37 20 35 12 296
Prisca Lo Surdo 245 33 3 58 12 321
Sandrine Ferrand 158 41 13 20 10 241
Christos Kannas 149 33 4 99 16 223
Ruijiang Li 169 43 7 46 13 230
Nitin Sharma 194 30 14 39 10 313
Olga Ivanova 173 13 11 27 8 245
Mingkun Lu 215 41 21 109 16 321
Caty Chung 237 24 7 113 9 305

All Works

Loading papers...

Rankless by CCL
2026